{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:31:18Z","timestamp":1773509478693,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.pathol.2017.10.012","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T14:06:34Z","timestamp":1518444394000},"page":"261-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cardiac amyloidosis: from clinical suspicion to morphological diagnosis"],"prefix":"10.1016","volume":"50","author":[{"given":"Pavla","family":"Flodrova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Flodr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Pika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Vymetal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusan","family":"Holub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Dzubak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Hajduch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlastimil","family":"Scudla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2017.10.012_bib1","first-page":"277","article-title":"Targeted treatment for amyloidosis","volume":"16","author":"Pepys-Vered","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.pathol.2017.10.012_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13506129.2014.964858","article-title":"Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis","volume":"21","author":"Sipe","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.pathol.2017.10.012_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","article-title":"Amyloidosis","volume":"57","author":"Pepys","year":"2006","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.pathol.2017.10.012_bib4","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","article-title":"Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics","volume":"99","author":"Vrana","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2017.10.012_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ajh.23456","article-title":"Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection\/tandem mass spectrometry","volume":"88","author":"D'Souza","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2017.10.012_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","article-title":"2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology","volume":"21","author":"Leone","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0046-8177(87)80361-1","article-title":"Endomyocardial biopsy: an overview","volume":"18","author":"Fenoglio","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10741-012-9355-6","article-title":"Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease","volume":"18","author":"Basso","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pathol.2017.10.012_bib10","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2017.10.012_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","article-title":"Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients","volume":"119","author":"Schonland","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7800-2-17","article-title":"Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis","volume":"2","author":"Srkalovic","year":"2005","journal-title":"Int Semin Surg Oncol"},{"key":"10.1016\/j.pathol.2017.10.012_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3324\/haematol.2015.133900","article-title":"Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis","volume":"101","author":"Bever","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2017.10.012_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/138161282104141204143657","article-title":"Contemporary treatment of amyloid heart disease","volume":"21","author":"Palecek","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pathol.2017.10.012_bib15","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2007.08.028","article-title":"Evaluation and management of the cardiac amyloidosis","volume":"50","author":"Selvanayagam","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2017.10.012_bib16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.amjmed.2011.04.013","article-title":"Cardiac amyloidosis: a practical approach to diagnosis and management","volume":"124","author":"Kapoor","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.pathol.2017.10.012_bib17","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2017.10.012_bib18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.acvd.2013.06.051","article-title":"Cardiac amyloidosis: updates in diagnosis and management","volume":"106","author":"Mohty","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.pathol.2017.10.012_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.pathol.2017.10.012_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.carpath.2012.09.001","article-title":"Relationship between monoclonal gammopathy and cardiac amyloid type","volume":"22","author":"Maleszewski","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib21","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(03)13396-X","article-title":"Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins","volume":"361","author":"Dispenzieri","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2017.10.012_bib22","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2017.10.012_bib23","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2004-01-0390","article-title":"Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2017.10.012_bib25","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood-2010-02-267708","article-title":"Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay","volume":"116","author":"Kristen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.amjcard.2012.05.061","article-title":"Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis","volume":"110","author":"Apridonidze","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pathol.2017.10.012_bib27","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2017.10.012_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/13506120903421538","article-title":"Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis","volume":"16","author":"Lehrke","year":"2009","journal-title":"Amyloid"},{"key":"10.1016\/j.pathol.2017.10.012_bib29","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pathol.2017.10.012_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","article-title":"Prognostic significance of strain doppler imaging in light-chain amyloidosis","volume":"3","author":"Koyama","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pathol.2017.10.012_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0735-1097(90)90545-Z","article-title":"Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis","volume":"16","author":"Klein","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2017.10.012_bib32","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pathol.2017.10.012_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/13506129.2016.1158160","article-title":"99m Tc-DPD scintigraphy as a novel imaging modality for identification of skeletal muscle amyloid deposition in light-chain amyloidosis","volume":"23","author":"Hutt","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.pathol.2017.10.012_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"99m Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","author":"Pilebro","year":"2015","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.pathol.2017.10.012_bib35","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cardfail.2016.10.008","article-title":"Transthyretin cardiac amyloidosis in older Americans","volume":"22","author":"Brunjes","year":"2016","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.pathol.2017.10.012_bib36","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2017.10.012_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pathol.2017.10.012_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1750-1172-7-54","article-title":"AL amyloidosis","volume":"7","author":"Desport","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pathol.2017.10.012_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/bjh.12269","article-title":"The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis","volume":"161","author":"Dinner","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2017.10.012_bib40","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ajh.21814","article-title":"Two distinct syndromes of lymphoma associated AL amyloidosis: a case series and review of the literature","volume":"85","author":"Telio","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2017.10.012_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.prp.2015.08.007","article-title":"Amyloid deposition in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a clinicopathologic study of 5 cases","volume":"212","author":"Zhang","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.pathol.2017.10.012_bib42","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1182\/blood-2010-06-290668","article-title":"Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features","volume":"116","author":"Kumar","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coph.2005.10.005","article-title":"Systemic amyloidosis","volume":"6","author":"Lachmann","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pathol.2017.10.012_bib44","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","article-title":"Amyloidosis: pathogenesis and new therapeutic options","volume":"29","author":"Merlini","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2017.10.012_bib45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ajh.20635","article-title":"AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes","volume":"81","author":"Sanchorawala","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2017.10.012_bib46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bjh.12286","article-title":"Systemic amyloidosis in England: an epidemiological study","volume":"161","author":"Pinney","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2017.10.012_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.blre.2012.03.001","article-title":"What do I need to know about immunoglobulin light chain (AL) amyloidosis?","volume":"26","author":"Dispenzieri","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.pathol.2017.10.012_bib48","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1182\/blood-2014-12-618108","article-title":"Hereditary systemic immunoglobulin light-chain amyloidosis","volume":"125","author":"Benson","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib49","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/WCO.0000000000000289","article-title":"First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy","volume":"29","author":"Adams","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.pathol.2017.10.012_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/postgradmedj-2014-133224","article-title":"The transthyretin amyloidoses: advances in therapy","volume":"91","author":"Dubrey","year":"2015","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.pathol.2017.10.012_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis","volume":"68","author":"Maurer","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2017.10.012_bib52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jcpt.12145","article-title":"Recent progress in the understanding and treatment of transthyretin amyloidosis","volume":"39","author":"Sekijima","year":"2014","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.pathol.2017.10.012_bib53","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/eurheartj\/ehr383","article-title":"Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant","volume":"33","author":"Sattianayagam","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pathol.2017.10.012_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pathol.2017.10.012_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pathol.2017.10.012_bib56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12383","article-title":"Cardiac amyloidosis: where are we today?","volume":"278","author":"Patel","year":"2015","journal-title":"J\u00a0Int Med"},{"key":"10.1016\/j.pathol.2017.10.012_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2016-01-629790","article-title":"What is new in diagnosis and management of light chain amyloidosis?","volume":"128","author":"Palladini","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","volume":"6","author":"Real de Asua","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.pathol.2017.10.012_bib59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cpcardiol.2012.11.002","article-title":"Current trends in diagnosis and management of cardiac amyloidosis","volume":"38","author":"Esplin","year":"2013","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.pathol.2017.10.012_bib60","first-page":"387","article-title":"Isolated atrial amyloidosis and the importance of molecular classification","volume":"26","author":"Podduturi","year":"2013","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.pathol.2017.10.012_bib61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000177950","article-title":"The association of atrial tachyarrhythmias with isolated atrial amyloid disease: preliminary observations in autopsied heart specimens","volume":"113","author":"Ariyarajah","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.pathol.2017.10.012_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-5793(98)00668-1","article-title":"Apolipoprotein A-I induced amyloidosis","volume":"430","author":"Genschel","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pathol.2017.10.012_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003063","article-title":"Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach","volume":"8","author":"Haase","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.pathol.2017.10.012_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9440(10)65268-6","article-title":"Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1","volume":"154","author":"Hamidi Asl","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib65","first-page":"267","article-title":"Reproducibility of morphometric measurements of amyloid after various staining methods","volume":"7","author":"Kosma","year":"1985","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1016\/j.pathol.2017.10.012_bib66","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jcp.22.4.410","article-title":"An evaluation of current methods for the diagnostic histochemistry of amyloid","volume":"22","author":"Cooper","year":"1969","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib67","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2017.10.012_bib68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3816\/CLML.2010.n.027","article-title":"Pitfalls in the diagnosis of primary amyloidosis","volume":"10","author":"Chee","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.pathol.2017.10.012_bib69","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00000478-200606000-00002","article-title":"Immunohistochemical classification of amyloid in surgical pathology revisited","volume":"30","author":"Kebbel","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib70","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2012-03-413682","article-title":"How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib71","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/PAS.0b013e3182263d74","article-title":"Strong transthyretin immunostaining","volume":"35","author":"Satoskar","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib72","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/prca.201200097","article-title":"Clinical proteomics for diagnosis and typing of systemic amyloidoses","volume":"7","author":"Brambilla","year":"2013","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.pathol.2017.10.012_bib73","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jclinpath-2014-202722","article-title":"A\u00a0comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue","volume":"68","author":"Gilbertson","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000447304","article-title":"A\u00a0more accurate approach to amyloid detection and subtyping: combining in situ Congo red staining and immunohistochemistry","volume":"84","author":"Menter","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.pathol.2017.10.012_bib75","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2014-11-609883","article-title":"A\u00a0practical approach to the diagnosis of systemic amyloidoses","volume":"125","author":"Fernandez de Larrea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2017.10.012_bib76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/13506120208995243","article-title":"Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis","volume":"9","author":"Arbustini","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.pathol.2017.10.012_bib77","first-page":"71","article-title":"Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis","volume":"39","author":"Fradley","year":"2012","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.pathol.2017.10.012_bib78","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.carpath.2008.05.004","article-title":"Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence","volume":"18","author":"Collins","year":"2009","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.pathol.2017.10.012_bib79","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2011-07-365510","article-title":"Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue","volume":"119","author":"Brambilla","year":"2012","journal-title":"Blood"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251730137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251730137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T15:02:50Z","timestamp":1656082970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130251730137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S003130251730137X"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2017.10.012","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac amyloidosis: from clinical suspicion to morphological diagnosis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2017.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}